Response to systemic therapy in fumarate hydratase–deficient renal cell carcinoma
Lucía Carril-Ajuria, Émeline Colomba, Luigi Cerbone, Carmen Romero, Laurence Crouzet, Brigitte Laguerre, Constance Thibault, Cécile Vicier, Guillermo de Velasco, Aude Fléchon, Carolina Saldana, Patrick R. Benusiglio, Brigitte Bressac–de Paillerets, Marine Guillaud-Bataille, Pauline Gaignard, Jean‐Yves Scoazec, Stéphane Richard, Olivier Caron, Bernard Escudier, Laurence Albigès
Topics & Concepts
MedicineSunitinibRenal cell carcinomaPazopanibInternal medicineNivolumabAxitinibOncologyCabozantinibTemsirolimusIpilimumabSorafenibPopulationResponse Evaluation Criteria in Solid TumorsErlotinibEverolimusCancerGastroenterologyPhases of clinical researchChemotherapyPI3K/AKT/mTOR pathwayDiscovery and development of mTOR inhibitorsHepatocellular carcinomaImmunotherapyBiochemistryApoptosisEpidermal growth factor receptorEnvironmental healthChemistryRenal cell carcinoma treatmentPancreatic and Hepatic Oncology ResearchRenal and related cancers